Business Description
Prothena Corp PLC
NAICS : 325412
SIC : 2834
ISIN : IE00B91XRN20
Share Class Description:
FRA:0PT: Ordinary SharesDescription
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 45.18 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 6 | |||||
| Beneish M-Score | -3.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 334 | |||||
| 3-Year EBITDA Growth Rate | -8.6 | |||||
| 3-Year EPS without NRI Growth Rate | 0.2 | |||||
| 3-Year FCF Growth Rate | -8.4 | |||||
| 3-Year Book Growth Rate | 31.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.9 | |||||
| 9-Day RSI | 55.14 | |||||
| 14-Day RSI | 52.67 | |||||
| 6-1 Month Momentum % | -20.74 | |||||
| 12-1 Month Momentum % | -58.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.52 | |||||
| Quick Ratio | 11.52 | |||||
| Cash Ratio | 11.19 | |||||
| Days Sales Outstanding | 9.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | -0.65 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -126.12 | |||||
| Net Margin % | -98.86 | |||||
| FCF Margin % | -114.29 | |||||
| ROE % | -23.56 | |||||
| ROA % | -19.93 | |||||
| ROIC % | -241.31 | |||||
| ROC (Joel Greenblatt) % | -1085.75 | |||||
| ROCE % | -27.47 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.25 | |||||
| PB Ratio | 1.52 | |||||
| Price-to-Tangible-Book | 1.48 | |||||
| EV-to-EBIT | -1.82 | |||||
| EV-to-EBITDA | -1.84 | |||||
| EV-to-Revenue | 2.3 | |||||
| EV-to-Forward-Revenue | 4.09 | |||||
| EV-to-FCF | -1.98 | |||||
| Price-to-Median-PS-Value | 0.02 | |||||
| Price-to-Net-Current-Asset-Value | 1.67 | |||||
| Price-to-Net-Cash | 1.73 | |||||
| Earnings Yield (Greenblatt) % | -54.95 | |||||
| FCF Yield % | -19.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prothena Corp PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 123.851 | ||
| EPS (TTM) (€) | -2.246 | ||
| Beta | -0.74 | ||
| Volatility % | 40.89 | ||
| 14-Day RSI | 52.67 | ||
| 14-Day ATR (€) | 0.801097 | ||
| 20-Day SMA (€) | 13.31 | ||
| 12-1 Month Momentum % | -58.84 | ||
| 52-Week Range (€) | 9.9 - 37 | ||
| Shares Outstanding (Mil) | 53.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prothena Corp PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prothena Corp PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prothena Corp PLC Frequently Asked Questions
What is Prothena Corp PLC(FRA:0PT)'s stock price today?
The current price of FRA:0PT is €14.30. The 52 week high of FRA:0PT is €37.00 and 52 week low is €9.90.
When is next earnings date of Prothena Corp PLC(FRA:0PT)?
The next earnings date of Prothena Corp PLC(FRA:0PT) is 2025-02-14 Est..
Does Prothena Corp PLC(FRA:0PT) pay dividends? If so, how much?
Prothena Corp PLC(FRA:0PT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers